Navigation Links
Ban On Trans Fats Comes Into Effect From July 1

Trans fats are chemically modified fats rich in cholesterol and known to cause heart disease. They are widely used as a substitute for saturated fats in bakery products//, fried foods like chips, salad dressings and other foods since long. Food prepared using trans fats is also believed to have a longer shelf life.

In a mighty effort to fight Obesity, the members of the New York City Board of Health, voted yesterday to ban the use of huge amounts of artificial trans fats in restaurants and bakeries.

Experts believe that eliminating trans fats will not change the taste of foods, but chefs and restaurant owners disagree, saying it will be difficult and more expensive to replicate the taste and texture of some menu items without them.

The health department’s restaurant inspectors will be in charge of enforcing both the trans fat and calorie regulations. Violators would have to face fines greater than $200. The Board of Health also demands that restaurants, especially fast food outlets, display the calorific value of each menu item on display boards.

The restaurant industry is highly agitated and accuses the government of interference into free enterprise and civil liberties.

“This is a misguided attempt at social engineering by a group of physicians who don’t understand the restaurant industry,” said Dan Flesher, a representative of National Restaurant Association. He said the association would challenge one or both measures legally.

Mayor Bloomberg said, “ the city is not going to take away anybody’s ability to go out and have the kind of food they want, in the quantities they want.”

“We are just trying to make food safer,” he added.

Restaurants have time until next July 1 to reduce usage of oils and margarine. Admissible fat level is a half-gram of trans fat per serving.

Posting caloric content also takes effect next July 1, this should not be a matter of co ncern for large chains restaurants with highly standardized menus.

Source-Medindi
PRI
'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Stem Cell Transplants May Be Effective For MS Patients
4. Transforming stem cells to lung cells
5. Alternative to blood Transfusions
6. Need for Blood Transfusions reduced
7. Drugs Deter Heart Disease for Transplant Patients
8. Better Drug for Heart Transplant
9. Kidney Failure after Non-Kidney Transplants
10. Measles Risk in Transplant Patients
11. West Nile and Blood Transfusions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... , ... “The Trials I Face to Receive God’s Grace”: a mesmerizing ... and goals to better one’s life through God. “The Trials I Face to Receive ... the wrong places, found a love for writing. Green feels that expressing his feelings ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... asked at a gathering of executive marketers this week about the value of ... , "Everything that has happened in business has brought us to the ...
(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring a church ... “They Sang At Her Funeral” is the creation of published author, Annalise Harold, an ... and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to relocate often ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a leading ... Denise Flannery, to its strategic advisory and client development team. , In ... with clients across different industries to develop and implement market-justified strategies, modernize and ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... that Scott McFarland has joined its executive team as the President of ... innovative value-based care management systems and contact centers. , “Scott is a ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
Breaking Medicine Technology: